Contemporary aspects of the diagnostics and conservative treatment of the lower urinary tract symptoms caused by BPH
Keywords:lower urinary tract symptoms, BPH, treatment, tamsulosin, Omnic
Lower urinary tract symptoms (LUTS) are referred to a group of medical symptoms that affect approximately 40% of men of older age and significantly affect their quality of life. Benign prostatic hyperplasia (BPH) is known to be the main cause of LUTS. Clinical manifestations caused by BPH are observed in 10% of men in the age group under 40 years old and in 40–61% of men under 70 years old. The objective of our study was to evaluate the efficacy and safety of Tamsulosin (Omnik, Astelas) in patients with LUTS caused by BPH. The study included 39 patients with LUTS against the background of BPH. The mean age of patients was 65.2±4.2 y. The criterion for inclusion into the study was the diagnosis of BPH, established on the basis of clinical symptoms, anamnesis, physical examination, the results of questionnaire by IPSS scale, quality of life index QoL, urinalysis, PSA, prostate and urinary tract ultrasound findings with determination of
the residual urine volume after urination, uroflowmetry data LUTS severity had decreased in the majority of patients following treatment with Omnik in dosage of 0.4 mg daily for 12 weeks. We have obtained statistically significant changes in the scores on the IPSS scale (International Prostate Symptom Score): prior to treatment 19.8±3.2 points, and at 12th week after treatment – 10.5±2.7 points. Changes in the maximum urine flow rate Qmax under the treatment demonstrated high efficiency of Omnik (before treatment – 6.6 ml/s, at the 4th week after treatment – 8.3 ml/s and at 12th week after treatment – 10.1 ml/s). There was a direct correlation between the effectiveness of LUTS treatment and duration of Tamsulosin administration. At that adverse effects occurred were rare, mild and did not require discontinuation of treatment or specific treatment.
Abrams P, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn, 2002. 21 (2): p. 167–78.
Chapple CR, et al. Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol, 2008. 54 (3): p. 563–9.
Novara G, et al. Critical Review of Guidelines for BPH Diagnosis and Treatment Strategy. Eur Urol Suppl 2006. 4: p. 418–29.
Martin SA, et al. Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. World J Urol, 2011. 29 (2): p. 179–84.
Societe Internationale d’Urologie (SIU), Lower Urinary Tract Symptoms (LUTS): An International Consultation on Male LUTS. C. Chapple and P. Abrams, Editors. 2013.
Kupelian V, et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med, 2006. 166 (21): p. 2381–7.
Agarwal A, et al. What is the most bothersome lower urinary tract symptom? Individual– and population-level perspectives for both men and women. Eur Urol, 2014. 65 (6): p. 1211–7.
Taub DA, et al. The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States. Curr Urol Rep, 2006. 7 (4): p. 272-81.
McVary KT, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol, 2011. 185 (5): p. 1793–803.
Bosch J, et al. Etiology, patient assessment and predicting outcome from therapy. In: Chapple C, Abrams P, editors. Male lower urinary tract symptoms. Montreal, Canada: International Consultation on Urological Diseases Male LUTS Guideline, 2013. p. 37–133.
Copyright (c) 2020 Ю. О. Мицик, Д. З. Воробець
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The journal does not require authors of original (primary) research papers to assign the copyright of their published contributions. Authors grant the journal an non-exclusive licence CC BY 4.0 (Creative Commons Attribution 4.0 International License) to using and the first publication of the original in this journal. Copyright of the manuscripts is retained by the authors, after publication authors retain rights to reuse their papers in their future printed work without first requiring permission from the publisher of the journal and share their own published articles.
The journal supports the self-archiving process. Prior to publication in the journal, authors may post a copy of their manuscript in preparation or submitted to the journal in recognized non-commercial preprint servers, public websites. Authors also are encouraged to archive their final author version of the manuscript in their institution's repositories and, if they wish, on their personal websites. Authors should cite the publication reference and DOI number on the first page of any deposited version, and provide a link from it to the URL of the published article on the journal's website.
To facilitate self-archiving of original research papers and help authors fulfil funder and institutional mandates, the journal deposits manuscripts in National Library of Ukraine by V.I. Vernadsky, Scientific periodicals of Ukraine database and different international scintificd database on behalf of authors who opt-in to this free service during submission. The journal provides depositing of articles on official website of the publisher. The full text access to published papers is free.